As AGF94 is transported by both FRs and the PCFT [147], this could represent a new approach for therapy of high-grade serous ovarian cancer through its ability to directly target the tumor via uptake by FRα and/or the PCFT and its effects on the TME, particularly FRβ-expressing TAMs. Here, FOLR2 is linked to neoplasm.